Quest Diagnostics Inc
(DGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 369,261 | 447,888 | 463,239 | 534,256 | 247,033 |
| Receivables | 884,094 | 869,643 | 865,160 | 827,343 | 888,288 |
| Inventories | 73,188 | 78,432 | 79,462 | 91,386 | 80,857 |
| Income taxes - deferred | 131,069 | 133,403 | 130,958 | 131,800 | 154,983 |
| TOTAL | $1,552,714 | $1,631,344 | $1,645,248 | $1,679,425 | $1,470,682 |
| Non-Current Assets | |||||
| PPE Net | 812,371 | 804,190 | 811,875 | 825,946 | 831,946 |
| Intangibles | 5,906,466 | 5,862,985 | 5,899,707 | 5,907,609 | 5,920,429 |
| Other Non-Current Assets | 187,788 | 183,273 | 159,379 | 150,663 | 142,667 |
| TOTAL | $6,906,625 | $6,850,448 | $6,870,961 | $6,884,218 | $6,895,042 |
| Total Assets | $8,459,338 | $8,481,792 | $8,516,209 | $8,563,643 | $8,365,725 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 331,526 | 171,128 | 170,404 | 170,507 | 103,872 |
| Accounts payable and accrued liabilities | 816,806 | 824,375 | 906,094 | 888,705 | 886,973 |
| TOTAL | $1,148,332 | $995,503 | $1,076,498 | $1,059,212 | $990,845 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,835,937 | 2,973,839 | 2,944,789 | 2,936,792 | 2,877,734 |
| Other Non-Current Liabilities | 584,683 | 556,301 | 557,002 | 547,203 | 549,623 |
| TOTAL | $3,430,301 | $3,539,401 | $3,510,496 | $3,492,967 | $3,436,773 |
| Total Liabilities | $4,578,633 | $4,534,904 | $4,586,994 | $4,552,179 | $4,427,618 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 170,405 | 177,214 | 179,929 | 178,917 | 184,901 |
| Common Shares | 2,142 | 2,142 | 2,142 | 2,141 | 2,141 |
| Retained earnings | 3,718,829 | 3,537,858 | 3,361,029 | 3,216,639 | 3,053,421 |
| Other shareholders' equity | 29,214 | -25,929 | 2,738 | 1,316 | 11,161 |
| TOTAL | $3,880,705 | $3,946,888 | $3,929,215 | $4,011,464 | $3,938,107 |
| Total Liabilities And Equity | $8,459,338 | $8,481,792 | $8,516,209 | $8,563,643 | $8,365,725 |